Radical hysterectomy alone or combined with neoadjuvant chemotherapy in the treatment of early stage bulky cervical carcinoma

Journal of the Formosan Medical Association

Volumn 101, Issue 3, 2002, Pages 195-202

  Chen, Chi An ^a   Cheng, Wen Fang ^a   Wei, Lin Hung ^a   Su, Yi Ning ^a   Hsieh, Chang Yao ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cervical carcinoma; Neoadjuvant chemotherapy; Survival

Indexed keywords

BLEOMYCIN; CISPLATIN; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PARITY; PROGNOSIS; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0036262379     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy postoperative pelvic irradiation
2. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone
3. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix
4. Local spread and lymph node involvement in cervical cancer
5. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma
6. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
7. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study
8. Cis-platinum in treatment of advanced of recurrent squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
9. A possible new trend in the management of the carcinoma of the cervix uteri
10. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results
11. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer
12. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy
13. High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervical carcinoma: A preliminary report
14. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma
15. Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIB-IVA cervical cancer. A preliminary study
16. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix
17. Prognostic significance of the depth of invasion relating to nodal metastases, parametrial extension, and cell types. A study of 628 cases with Stage IB, IIA, and IIB cervical carcinoma
18. Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer
19. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer
20. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix
21. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer
22. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
23. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
24. Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer
25. Cisplatin induces radioprotection in human T98G glioma cells
26. Transvaginal color Doppler ultrasound for monitoring the response to neoadjuvant chemotherapy in advanced cervical cancer
27. Cervical cancer response to neoadjuvant therapy: MR imaging assessment